Cargando…
Longitudinal analysis of colon crypt stem cell dynamics in sulindac treated Familial Adenomatous Polyposis patients
The non-steroidal anti-inflammatory drug sulindac decreases size and number of adenomas after 4-6 months of treatment for familial adenomatous polyposis (FAP) patients. However, the underlying mechanism remains unknown. As stem cells are thought to be the tumor precursor cells, visualizing their beh...
Autores principales: | Ma, Huiying, Brosens, Lodewijk A. A., Elias, Sjoerd G., Morsink, Folkert H. M., Nijman, Isaac J., Hylind, Linda M., Montgomery, Elizabeth A., Offerhaus, G. Johan A., Giardiello, Francis M., de Leng, Wendy W. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607292/ https://www.ncbi.nlm.nih.gov/pubmed/28931879 http://dx.doi.org/10.1038/s41598-017-11865-y |
Ejemplares similares
-
Sulindac targets nuclear β-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines
por: Boon, E M J, et al.
Publicado: (2004) -
Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis
por: Friederich, Pieter, et al.
Publicado: (2011) -
LKB1 as the ghostwriter of crypt history
por: Jansen, Marnix, et al.
Publicado: (2011) -
Familial adenomatous polyposis
por: Half, Elizabeth, et al.
Publicado: (2009) -
Colon Crypts of Subjects With Familial Adenomatous Polyposis Show an Increased Number of LGR5+ Ectopic Stem Cells
por: Jennelle, Lucas T., et al.
Publicado: (2021)